Clinical evidence for Low-Intensity Vibration.
A curated selection of peer-reviewed studies examining the safety and efficacy of Low-Intensity Vibration therapy for bone density, falls prevention, and musculoskeletal health across diverse patient groups.
Decades of research into Low-Intensity Vibration.
Marodyne LiV is backed by more than 60 peer-reviewed studies covering osteoporosis, osteopenia, sarcopenia, falls prevention, muscle strength, paediatric bone conditions, spinal cord injury and metabolic bone disease. Studies span leading journals including JBMR, Osteoporosis International, Nature Reviews Endocrinology, Gait & Posture and the Journal of Science and Medicine in Sport.
The research demonstrates safe, measurable improvements in bone mineral density (BMD), trabecular bone quality, muscle mass, balance and fall incidence — across post-menopausal women, older adults, cancer survivors and children.
Every study, with the full paper attached.
Each entry links directly to the original PDF (or manuscript) so you — or your clinician — can review the methods, cohort, endpoints and results in full.
- 2011Gait & PosturePostural stability
Postural instability caused by extended bed rest is alleviated by brief daily exposure to low magnitude mechanical signals
Jesse Muir, Stefan Judex, Yi-Xian Qin, Clinton Rubin
Randomised trial showing that just minutes a day of low-magnitude vibration protected postural control in adults exposed to prolonged bed rest — mirroring the disuse conditions that accelerate bone and balance loss with age.
- 2013Journal of Science and Medicine in SportDevice safety
Safety and severity of accelerations delivered from whole body vibration exercise devices to standing adults
JSMAS Safety Study
Independent assessment of commercial vibration platforms found many exceed ISO / occupational safety thresholds for daily exposure — establishing why low-magnitude signals (like Marodyne's 0.4g) sit within safe limits while high-intensity gym plates do not.
- 2014Osteoporosis InternationalFalls & fractures — RCT
Effects of 18-month low-magnitude high-frequency vibration on fall rate and fracture risks in 710 community elderly — a cluster-randomised controlled trial
Leung et al.
Large 18-month cluster-randomised trial in 710 community-dwelling elderly women. Low-magnitude high-frequency vibration significantly reduced fall rate and fracture risk versus control — the landmark falls-prevention study for LiV.
- 2019Nature Reviews EndocrinologyMechanism review
Combating osteoporosis and obesity with exercise: leveraging cell mechanosensitivity
Nature Reviews Endocrinology
Comprehensive review of how mechanical signals steer mesenchymal stem cells toward bone rather than fat, and how low-magnitude vibration replicates the anabolic signals of exercise for people who cannot train intensely.
- 2020JBMRPost-menopausal bone
Effect of Low-Intensity Vibration on Bone Strength, Microstructure, and Adiposity in Pre-Osteoporotic Postmenopausal Women: A Randomised Placebo-Controlled Trial
JBMR — LiV Postmeno MRI
Placebo-controlled RCT using high-resolution MRI showed LiV improved trabecular bone microstructure and strength, and reduced marrow adiposity in pre-osteoporotic post-menopausal women — evidence at the tissue level, not just DEXA.
- 2021Research CompendiumEvidence summary
Marodyne & Osteoporosis Prevention: Updated Research & Evidence (Nov 2021)
Marodyne research compendium
Consolidated overview of the accumulated LiV evidence base as of late 2021, covering BMD, trabecular quality, muscle, balance and safety across post-menopausal, paediatric and disuse populations.
- —Spinal Cord Injury ResearchSignal transmission
Transmission of low-intensity vibration through the axial skeleton of persons with spinal cord injury as a potential intervention for preservation of bone quantity and quality
Bauman et al.
Demonstrates that low-intensity mechanical signals travel efficiently up the axial skeleton even in individuals with spinal cord injury — supporting LiV as a viable intervention where weight-bearing exercise is not possible.
- —Current Opinion in Endocrinology, Diabetes & ObesityClinical review
Vibration therapy: clinical applications in bone
Current Opinion review
Clinical review summarising how vibration therapy is applied across osteoporosis, disuse osteopenia, paediatric bone disease and cancer-related bone loss — with clear separation between low-intensity therapeutic devices and high-magnitude platforms.
PDFs are hosted by the original publisher or the Marodyne research archive. Copyright of each paper remains with its respective authors and journal.
Safe by design
0.4g at 30 Hz sits well below ISO occupational vibration limits — evidenced in the 2013 JSMAS safety paper.
Tissue-level change
The 2020 JBMR MRI trial showed improvements in trabecular microstructure and reduced marrow fat — not just DEXA scores.
Studied across ages
Evidence spans post-menopausal women, older adults at fall risk, children with cerebral palsy and spinal cord injury patients.
Explore falls prevention research
Two long-term controlled trials showed a 46% reduction in falls for elderly women using Low-Intensity Vibration, with benefits maintained a year after stopping treatment.
See the falls prevention dataResearch questions, answered.
- Is Low-Intensity Vibration (LiV) therapy clinically proven for osteoporosis?
- Yes. More than 35 peer-reviewed studies — including randomised controlled trials published in JBMR, Osteoporosis International and Nature Reviews Endocrinology — have shown that Low-Intensity Vibration can improve bone mineral density (BMD), trabecular microarchitecture and muscle strength in post-menopausal women and other at-risk groups.
- How is Marodyne LiV different from whole-body vibration (WBV) platforms?
- Marodyne LiV delivers precisely calibrated low-magnitude (0.4g) high-frequency (30 Hz) vibration, which research has shown is safe and osteogenic. Traditional whole-body vibration devices operate at much higher accelerations that may exceed ISO safety thresholds for daily use.
- What bone density improvements have clinical trials measured?
- Published trials have reported improvements of approximately 2.1% in bone mineral density at the spine and hip in post-menopausal women after 12 months of daily LiV therapy, alongside gains in trabecular bone quality measured by high-resolution MRI.
- Which patient groups have been studied with LiV therapy?
- Research covers post-menopausal women with osteopenia and osteoporosis, older adults at risk of falls, children with cerebral palsy and disuse osteoporosis, cancer survivors, and adults with spinal cord injury.
- How long do I need to stand on the device each day?
- The clinically studied protocol is 10 minutes of standing per day, at least 5 days per week. Benefits to bone, balance and muscle strength have been demonstrated across 12- to 18-month intervention periods.